This site uses cookies to store information on your computer. Learn more x

Consensus Figures

A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the banks that were approached by Vara Research.

Analysts' consensus Q4 2017, FY 2017 and FY2018 published 20 November 2017

  Q4 2016 FY 2016 Q3 2017 Q4 2017E FY 2017E FY 2018E
Sales (continuing)            
Number of Estimates       18 18 18
Highest       2,150 8,606 9,061
Consensus 2,015 7,920 2,136 2,071 8,527 8,807
Median       2,067 8,523 8,791
Lowest       1,968 8,424 8,544
Adj. EBITDA (continuing)            
Number of Estimates       18 18 18
Highest       353 1,439 1,577
Consensus 315 1,262 365 339 1,425 1,506
Median       340 1,426 1,504
Lowest       325 1,411 1,459
Adj. EBIT (continuing)            
Number of Estimates       17 18 18
Highest       231 948 1,073
Consensus 190 791 239 213 930 1,007
Median       218 935 1,004
Lowest       124 841 929
Nutrition, Sales            
Number of Estimates       18 18 18
Highest       1,396 5,547 5,847
Consensus 1,321 5,169 1,373 1,330 5,481 5,654
Median       1,330 5,481 5,632
Lowest       1,172 5,323 5,452
Nutrition, adj. EBITDA            
Number of Estimates       18 18 18
Highest       265 1,051 1,140
Consensus 238 931 258 251 1,037 1,097
Median       251 1,037 1,102
Lowest       233 1,019 1,053
Nutrition, adj. EBIT            
Number of Estimates       16 16 16
Highest       190 765 841
Consensus 160 645 192 178 753 804
Median       180 755 808
Lowest       170 745 760
Materials, Sales            
Number of Estimates       18 18 18
Highest       725 2,857 3,019
Consensus 639 2,513 706 678 2,810 2,906
Median       677 2,809 2,913
Lowest       652 2,784 2,741
Materials, adj. EBITDA            
Number of Estimates       18 18 18
Highest       118 487 516
Consensus 105 435 128 112 481 496
Median       113 482 499
Lowest       101 470 464
Materials, adj. EBIT            
Number of Estimates       16 16 16
Highest       88 363 380
Consensus 77 311 98 80 355 367
Median       81 357 371
Lowest       72 347 337
Innovation Center, Sales            
Number of Estimates       17 17 17
Highest       53 179 193
Consensus 41 167 42 44 170 179
Median       44 170 178
Lowest       39 165 168
Innovation Center, adj. EBITDA            
Number of Estimates       17 17 17
Highest       4 9 20
Consensus -1 1 4 1 6 9
Median       1 6 10
Lowest       -1 4 0
Innovation Center, adj. EBIT            
Number of Estimates       15 15 15
Highest       8 -21 -10
Consensus -9 -24 -17 -5 -34 -23
Median       -6 -35 -20
Lowest       -20 -49 -42
Corporate Activities, Sales            
Number of Estimates       17 17 17
Highest       28 75 80
Consensus 14 71 15 20 67 68
Median       18 65 66
Lowest       13 60 60
Corporate Activities, adj. EBITDA            
Number of Estimates       17 17 17
Highest       -22 -96 -79
Consensus -27 -105 -25 -26 -100 -99
Median       -25 -99 -101
Lowest       -31 -105 -107
Corporate Activities, adj. EBIT            
Number of Estimates       15 15 15
Highest       -29 -133 -117
Consensus -38 -141 -34 -36 -140 -139
Median       -35 -139 -141
Lowest       -43 -147 -149
adj. Net Profit for the period, before exceptional items - Cont. Ops.            
Number of Estimates       17 17 17
Highest       229 733 828
Consensus 130 508 166 167 669 742
Median       156 658 741
Lowest       140 644 623
adj. Net EPS before exceptional items - Cont. Ops.            
Number of Estimates       17 17 17
Highest       1.32 4.21 4.69
Consensus 0.73 2.89 0.91 0.95 3.78 4.21
Median       0.89 3.73 4.21
Lowest       0.77 3.58 3.56

DSM Disclaimer

Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.